Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v7-EN | Version v3-FR | |
|---|---|---|
| Language | English | French |
| Date Updated | 2017-03-13 | 2017-03-13 |
| Drug Identification Number | 00428833 | 00428833 |
| Brand name | YF-VAX (YELLOW FEVER VACCINE) | YF-VAX (YELLOW FEVER VACCINE) |
| Common or Proper name | YELLOW FEVER VACCINE | YELLOW FEVER VACCINE |
| Company Name | SANOFI PASTEUR LIMITED | SANOFI PASTEUR LIMITED |
| Ingredients | Yellow fever virus strain 17D-204 | Yellow fever virus strain 17D-204 |
| Strength(s) | 109648PFU | 109648PFU |
| Dosage form(s) | POWDER FOR SOLUTION | POWDER FOR SOLUTION |
| Route of administration | INTRAMUSCULAR | INTRAMUSCULAR |
| Packaging size | 5 x 0.5 mL dose vials with diluent / 5 fioles de 1 dose de 0,5 mL avec diluant | 5 x 0.5 mL dose vials with diluent |
| ATC code | J07BL | J07BL |
| ATC description | VIRAL VACCINES | VIRAL VACCINES |
| Reason for shortage | Disruption of the manufacture of the drug. | Other (Please describe in comments) |
| Anticipated start date | 2016-11-08 | 2016-11-08 |
| Actual start date | 2016-11-08 | 2016-11-08 |
| Estimated end date | Unknown | Unknown |
| Actual end date | ||
| Shortage status | Actual shortage | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Supply disruptions are anticipated only in the private market. No disruption to publicly funded immunization programs is expected. | Supply disruptions are anticipated only in the private market. No disruption to publicly funded immunization programs is expected. |
| Health Canada comments |